Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics.
Kosse LJ, Weits G, Vonkeman HE, Spuls PI, Van Den Bemt BJF, Tas SW, Hoentjen F, Nurmohamed MT, Van Doorn MBA, Van Puijenbroek EP, Jessurun NT.
Kosse LJ, et al. Among authors: van doorn mba, van puijenbroek ep, van den bemt bjf.
Expert Opin Drug Saf. 2020 Aug;19(8):1049-1054. doi: 10.1080/14740338.2020.1781090. Epub 2020 Jul 7.
Expert Opin Drug Saf. 2020.
PMID: 32524887